AstraZeneca invests $200m in local manufacturing

AstraZeneca invests $200m in local manufacturing

AstraZeneca has committed $200m to its Macquarie Park manufacturing facility.  The North Ryde facility is among the most digitised and innovative in the company’s global network, delivering millions of medicines to millions of patients who need them in Australian, Asia-Pacific and global markets.

READ MORE